BRIGHTPLEX
LIVE

Serial Number

79260990

Owner

HalioDx

Attorney

Timothy Dell Nichols

Filing Date

Apr 18, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BRIGHTPLEX Trademark

Serial Number: 79260990 • Registration: 5958367

BRIGHTPLEX is a trademark filed by HalioDx on April 18, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

HalioDx (6 trademarks)

163 Avenue de Luminy,
F-13288 Marseille Cédex 09 , FR

Entity Type: 34

VERACYTE (7 trademarks)

PARC SCIENTIFIQUE DE LUMINY

Entity Type: 34

Trademark Details

Filing Date

April 18, 2019

Registration Date

January 14, 2020

Published for Opposition

October 29, 2019

Goods & Services

Recorded software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatment and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition

Pharmaceutical preparations for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing diagnostic or identification information of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising biological markers, reagents and medical tests for diagnostic purposes, for testing biological tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis

Medical analysis services, namely, analysis of tumor, cancer or equivalent medical condition; medical assistance; health care services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic and tissue analysis services for medical purposes; medical testing services for the detection, quantification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis, namely, analyzing the immune contexture of a tumor

Research, development, technical design and scientific testing services in the field of oncology; industrial analysis and research services in the field of oncology; clinical trial services for others; tests in laboratories, namely, analysis of biological mechanisms of actions, biomarkers and signatures for research in biology purposes; development of quality control testing methods for others; research, development, technical design, testing, consulting and analysis services in the field of immunology and oncology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of immune repertoire analysis and the genome; design and development of software in the field of biology

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 21, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 14, 2025 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 12, 2022 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
May 22, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 24, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 24, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 14, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 14, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 29, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 29, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 26, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 9, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 9, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 9, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 18, 2019 CRFA
ASSIGNED TO LIE
Sep 17, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2019 TROA
REFUSAL PROCESSED BY IB
Aug 9, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 22, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jul 22, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 30, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 29, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 25, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 20, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 13, 2019 REPR